This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ahn, Y.-H. Articles by Hong, S. H. Search for Related Content PubMed PubMed Citation Articles by Ahn, Y.-H. Articles by Hong, S. H.

8-Chloro-Cyclic AMP–Induced Growth Inhibition and Apoptosis Is Mediated by p38 Mitogen-Activated Protein Kinase Activation in HL60 Cells

¹ School of Biological Sciences, ² Institute of Molecular Biology and Genetics, and ³ Interdisciplinary Graduate Program in Genetic Engineering, Seoul National University, Seoul, Korea

Requests for reprints: Seung Hwan Hong, Institute of Molecular Biology and Genetics, Seoul National University, Seoul 151-742, Korea. Phone: 822-880-6776; Fax: 822-888-8577; E-mail: shong{at}plaza.snu.ac.kr.

8-Chloro-cyclic AMP (8-Cl-cAMP), which is known to induce growth inhibition, apoptosis, and differentiation in various cancer cell lines, has been studied as a putative anticancer drug. However, the mechanism of anticancer activities of 8-Cl-cAMP has not been fully understood. Previously, we reported that the 8-Cl-cAMP-induced growth inhibition is mediated by protein kinase C (PKC) activation. In this study, we found that p38 mitogen-activated protein kinase (MAPK) also plays important roles during the 8-Cl-cAMP-induced growth inhibition and apoptosis. SB203580 (a p38-specific inhibitor) recovered the 8-Cl-cAMP-induced growth inhibition and apoptosis, whereas other MAPK inhibitors, such as PD98059 (an extracellular signal-regulated kinase–specific inhibitor) and SP600125 (a c-Jun NH₂-terminal kinase–specific inhibitor), had no effect. The phosphorylation (activation) of p38 MAPK was increased in a time-dependent manner after 8-Cl-cAMP treatment. Furthermore, SB203580 was able to block PKC activation induced by 8-Cl-cAMP. However, PKC inhibitor (GF109203x) could not attenuate p38 activation, indicating that p38 MAPK activation is upstream of PKC activation during the 8-Cl-cAMP-induced growth inhibition. 8-Chloro-adenosine, a metabolite of 8-Cl-cAMP, also activated p38 MAPK and this activation was blocked by adenosine kinase inhibitor. These results suggest that 8-Cl-cAMP exerts its anticancer activity through p38 MAPK activation and the metabolite(s) of 8-Cl-cAMP mediates this process.

This article has been cited by other articles:

				M. Fryknas, L. Rickardson, M. Wickstrom, S. Dhar, H. Lovborg, J. Gullbo, P. Nygren, M. G. Gustafsson, A. Isaksson, and R. Larsson Phenotype-Based Screening of Mechanistically Annotated Compounds in Combination with Gene Expression and Pathway Analysis Identifies Candidate Drug Targets in a Human Squamous Carcinoma Cell Model J Biomol Screen, August 1, 2006; 11(5): 457 - 468. [Abstract] [PDF]